4Bio Capital, a London-based venture capital (VC) firm, is looking to close its third fund in the first half of next year with plans to invest in advanced therapeutic companies in Asia as part of its decade-long strategy, a top executive told DealStreetAsia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
